Replies to post #2099 on VistaGen Therapeutics Inc (VTGN)

[Bluechipper]

What a load of crap, the filing period ended Tuesday July 30th, the filing was made on Friday Aug. 2nd after the BGMO halt. Autilion is the BGMO European subsidiary that is funding VSTA and has nothing to do with the software website

Shawn K. Singh, VistaGen's Chief Executive Officer, stated, "I met with Autilion's team earlier this week, and we have been working closely with them since signing our agreement in April. We are confident and excited about completing this transformative financing. Building on the positive developments in our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our shareholders."

http://www.otcmarkets.com/stock/VSTA/filings